FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes a novel compound 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)[1,5-a]-1,3,5-triazine of the formula (I):
, its steroisomeric forms or pharmaceutically acceptable salts, pharmaceutical composition comprising thereof and its using for preparing pharmaceutical composition used in treatment of anxiety in mammals.
EFFECT: valuable medicinal property of compound and pharmaceutical composition.
7 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BICYCLIC DERIVATIVES, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, THEIR USING IN TREATMENT AND METHOD FOR TREATMENT OF MAMMALS BY THEIR USING | 2002 |
|
RU2310655C2 |
| CONDENSED HETEROCYCLIC COMPOUNDS | 2006 |
|
RU2408586C2 |
| CRF-RECEPTOR ANTAGONISTS AND TECHNIQUES RELATING TO THEM | 2004 |
|
RU2394035C2 |
| DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
| 1, 2, 4-TRIAZINE-3, 5-DIONE DERIVATIVES FOR TREATING DISORDERS REACTING ON DOPAMINE D RECEPTOR MODULATION | 2008 |
|
RU2478633C2 |
| HETEROCYCLIC COMPOUNDS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2015 |
|
RU2667498C2 |
| TRIAZOLES FOR REGULATION OF INTRACELLULAR CALCIUM HOMEOSTASIS | 2017 |
|
RU2753509C2 |
| PIRAZOLOIMIDAZOPYRIMIDINE DERIVATIVES WITH ANTAGONIST ACTIVITY TO CORTICOTROPHIN RELEASE FACTOR (CRF) | 2004 |
|
RU2377241C2 |
| 7-PHENYLPYRAZOLOPYRIDINE COMPOUNDS | 2003 |
|
RU2327699C2 |
| DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS | 2001 |
|
RU2296124C2 |
